Lamivudine
Product Images NDC 68180-603

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Lamivudine (NDC 68180-603). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image-01 (86a45a3b A934 417d Bc27 6d18fbff5f2d 01)

FDA Label Image

Image-02 (86a45a3b A934 417d Bc27 6d18fbff5f2d 02)

Image-02 (86a45a3b A934 417d Bc27 6d18fbff5f2d 02)
The text appears to be a graph showing the proportion of subjects with HIV-1 RNA less than 400 copies/mL over a period of 32 weeks. The graph compares two treatment options - Lamivudine 150mg twice daily and Lamivudine 300mg once daily.*
FDA Label Image

Image-03 (86a45a3b A934 417d Bc27 6d18fbff5f2d 03)

Image-03 (86a45a3b A934 417d Bc27 6d18fbff5f2d 03)
This is a prescription drug manufactured by Lupin Pharmaceuticals, Inc. NDC 68180-602-07 is the identification code for this particular drug. The drug contains 150 mg of lamivudine USP and comes in a container with 60 tablets. The recommended storage temperature is between 15°C to 30°C (59°F to 86°F). More information on the dosage can be found on the prescribing information accompanying the drug. The manufacturer is Lupin Limited and the drug code is GO/DRUGS/654.*
FDA Label Image

Image-04 (86a45a3b A934 417d Bc27 6d18fbff5f2d 04)

Image-04 (86a45a3b A934 417d Bc27 6d18fbff5f2d 04)
This is a medication called Lamivudine manufactured by Lupin Pharmaceuticals, Inc. It contains 300 mg of lamivudine per film-coated tablet, and should be stored at 25°C (77°F) with a permitted range of 15°C to 30°C (59°F to 86°F). The dosage information can be found in the accompanying prescribing information. The tablets are controlled by USP and Lupin Limited in Goa, India.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.